![Garth Lees-Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garth Lees-Rolfe
Direktor/Vorstandsmitglied bei
LUDWIG ENTERPRISES, INC.
Profil
Garth Lees-Rolfe currently works at Ludwig Enterprises, Inc., as Independent Director from 2025.
Mr. Lees-Rolfe also formerly worked at F-star Therapeutics, Inc., as Vice President-Finance from 2021 to 2022 and Inhibikase Therapeutics, Inc., as Chief Financial & Accounting Officer from 2024 to 2025.
Mr. Lees-Rolfe received his undergraduate degree from Queensland University of Technology.
Aktive Positionen von Garth Lees-Rolfe
| Unternehmen | Position | Beginn |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Direktor/Vorstandsmitglied | 23.06.2025 |
Ehemalige bekannte Positionen von Garth Lees-Rolfe
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Finanzdirektor/CFO | 11.04.2025 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2022 |
Ausbildung von Garth Lees-Rolfe
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
 Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
